NEW YORK (GenomeWeb) – Genedrive announced today that it has partnered with the Foundation for Innovative New Diagnostics (FIND) to begin a study to evaluate the firm's hepatitis C Virus ID Kit.

Genedrive's HCV ID Kit runs on the firm's portable molecular diagnostics platform and is designed for use in low-resource settings, delivering results in 90 minutes. The platform uses PCR amplification and melt curve analysis to rapidly amplify and detect target nucleic acid sequences without the need for nucleic acid isolation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.